FAM224A: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker for Alzheimer's Disease

Target Name: FAM224A

NCBI ID: G401630

FAM224A

Other Name(s): LINC00230A | NCRNA00230A | family with sequence similarity 224 member A | Family with sequence similarity 224 member A

FAM224A: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker for Alzheimer's Disease

FAM224A (LINC00230A) is a non-coding RNA molecule that has been identified as a potential drug target (or biomarker) in the field of neurodegenerative diseases, specifically in the context of Alzheimer's disease. The molecule is located in the protein coding gene for the neurotransmitter dopamine.

The exact function of FAM224A is not yet fully understood, but research has shown that it plays a role in the regulation of dopamine signaling in the brain. Specifically, the molecule has been shown to interact with the dopamine receptor, which is a transmembrane protein that plays a crucial role in the transmission of dopamine signals in the brain.

One of the most promising aspects of FAM224A is its potential as a drug target. Researchers are investigating the use of small molecules or antibodies to target the molecule and disrupt its function in the context of Alzheimer's disease. The goal is to reduce the production of beta-amyloid plaques, a hallmark of Alzheimer's disease, and improve overall cognitive function in the disease.

Another promising aspect of FAM224A is its potential as a biomarker. The molecule has been shown to be expressed in the brains of individuals with Alzheimer's disease, and its levels have been correlated with the severity of the disease. This suggests that FAM224A may be a useful diagnostic tool for the disease, as well as a target for new treatments.

While more research is needed to fully understand the function and potential of FAM224A, its potential as a drug target and biomarker is an exciting area of study. The discovery of new RNA molecules that can be targeted with small molecules or antibodies may lead to new treatments for neurodegenerative diseases, including Alzheimer's disease.

In conclusion, FAM224A is a promising RNA molecule that has the potential to be a drug target or biomarker in the field of neurodegenerative diseases, particularly in the context of Alzheimer's disease. Further research is needed to fully understand its function and potential as a therapeutic tool.

Protein Name: Family With Sequence Similarity 224 Member A

The "FAM224A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM224A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets